The company expects to invest up to $200m in the approximately 120,000ft² biomanufacturing plant at its West Greenwich campus in Rhode Island. Amgen will use its next-generation biomanufacturing
The post Amgen breaks ground on $200m biomanufacturing facility in US appeared first on Pharma Business review.
Original Article: Amgen breaks ground on $200m biomanufacturing facility in US